133 related articles for article (PubMed ID: 16097569)
1. Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancer.
Duff SE; Saunders M; McCredie V; Kumar S; O'Dwyer ST; Jayson GC
Clin Oncol (R Coll Radiol); 2005 Aug; 17(5):367-71. PubMed ID: 16097569
[TBL] [Abstract][Full Text] [Related]
2. Serum vascular endothelial growth factor-C and vascular endothelial growth factor level in patients with colorectal carcinoma and clinical significance.
Xu T; Chen D
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):329-31, 355. PubMed ID: 16961284
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of vascular endothelial growth factors and their relationships to lymph node metastasis in human colorectal cancer.
Kawakami M; Furuhata T; Kimura Y; Yamaguchi K; Hata F; Sasaki K; Hirata K
J Exp Clin Cancer Res; 2003 Jun; 22(2):229-37. PubMed ID: 12866573
[TBL] [Abstract][Full Text] [Related]
4. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
Tamura M; Ohta Y
Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor-C (VEGF-C) is a more specific risk factor for lymph node metastasis than VEGF-D in submucosal colorectal cancer.
Kazama S; Watanabe T; Kanazawa T; Hatano K; Nagawa H
Hepatogastroenterology; 2007; 54(73):71-6. PubMed ID: 17419234
[TBL] [Abstract][Full Text] [Related]
6. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
8. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
Niki T; Iba S; Tokunou M; Yamada T; Matsuno Y; Hirohashi S
Clin Cancer Res; 2000 Jun; 6(6):2431-9. PubMed ID: 10873096
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
11. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
Kocael A; Vatankulu B; Şimşek O; Cengiz M; Kemik A; Kocael P; Halaç M; Sönmezoğlu K; Ulualp K
Tumour Biol; 2016 Mar; 37(3):3871-7. PubMed ID: 26476536
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
Eroğlu A; Ersöz C; Karasoy D; Sak S
Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
[TBL] [Abstract][Full Text] [Related]
13. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
Fukunaga S; Maeda K; Noda E; Inoue T; Wada K; Hirakawa K
Oncology; 2006; 71(3-4):204-11. PubMed ID: 17641542
[TBL] [Abstract][Full Text] [Related]
14. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer.
Kawakami M; Furuhata T; Kimura Y; Yamaguchi K; Hata F; Sasaki K; Hirata K
Surgery; 2003 Mar; 133(3):300-8. PubMed ID: 12660643
[TBL] [Abstract][Full Text] [Related]
15. Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?
Tsirlis TD; Papastratis G; Masselou K; Tsigris C; Papachristodoulou A; Kostakis A; Nikiteas NI
World J Gastroenterol; 2008 May; 14(17):2691-701. PubMed ID: 18461654
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of preoperative serum vascular endothelial growth factor levels in patients with colorectal cancer and the effect of tumor surgery.
Karayiannakis AJ; Syrigos KN; Zbar A; Baibas N; Polychronidis A; Simopoulos C; Karatzas G
Surgery; 2002 May; 131(5):548-55. PubMed ID: 12019409
[TBL] [Abstract][Full Text] [Related]
17. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H
Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025
[TBL] [Abstract][Full Text] [Related]
18. [Effect of the levels of vascular endothelial growth factor-A and C on the prognosis of patients with laryngeal carcinoma].
Düzen B; Taş A; Demir M; Usta U; Yağız R; Koten M; Karasalihoğlu A
Kulak Burun Bogaz Ihtis Derg; 2011; 21(3):122-8. PubMed ID: 21595615
[TBL] [Abstract][Full Text] [Related]
19. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
20. Predictive significance of preoperative serum VEGF-C and VEGF-D, independently and combined with Ca19-9, for the presence of malignancy and lymph node metastasis in patients with gastric cancer.
Tsirlis TD; Kostakis A; Papastratis G; Masselou K; Vlachos I; Papachristodoulou A; Nikiteas NI
J Surg Oncol; 2010 Nov; 102(6):699-703. PubMed ID: 20672317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
